Anna Vera de Jonge
10PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Oct 07, 2025
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels.Wassilis S C Bruins, Febe Smits, Carolien Duetz
|Aug 19, 2025
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.Wassilis S C Bruins, Febe Smits, Carolien Duetz
|Feb 28, 2025
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.Charlotte L B M Korst, Sabrin Tahri, Carolien Duetz
|Nov 27, 2024
Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies.Anna Vera de Jonge, Tamás Csikós, Merve Eken
|Jan 08, 2024
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.A Vera de Jonge, Carolien Duetz, Wassilis S C Bruins
|Jan 04, 2024
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma.A V de Jonge, J A A Bult, D F E Karssing
Pageof 2
Frequent Collaborators
4 joint publications
Tuna Mutis
4 joint publications
Wassilis S C Bruins
3 joint publications
Martine E D Chamuleau
3 joint publications
Rosa Rentenaar
2 joint publications
Marcel Nijland
2 joint publications
Pieter Sonneveld
2 joint publications
Margaretha G M Roemer
2 joint publications
Sonja Zweegman
2 joint publications
Daphne de Jong
2 joint publications
Erik van Werkhoven
